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Objective: Increased awareness around neurocognitive deficits after mild traumatic 
brain injury (mTBI) has progressed the search for objective, diagnostic, and monitoring 
tools, yet imaging biomarkers for mTBI and recovery are not established in clinical use. 
It has been suggested that mTBI impairs cerebrovascular reactivity (CVR) to CO2, which 
could be related to post-concussive syndrome (PCS). We investigate CVR evolution after 
mTBI using blood-oxygen-level dependent (BOLD) magnetic resonance imaging (MRI) 
and possible correlation with PCS.
Methods: A prospective cohort of 25 mTBI patients and 18 matched controls under-
went BOLD MRI CVR measurements. A subset of 19 mTBI patients underwent follow-up 
testing. Visits took place at a mean of 63 and 180 days after injury. Symptoms were 
assessed with the Sport Concussion Assessment Tool 2 (SCAT2). Symptoms, CVR and 
brain volume [gray matter (GM), white matter (WM), and whole brain (WB)], age, and 
sex, were examined between groups and longitudinally within traumatic brain injury (TBI) 
patients.
results: Traumatic brain injury participants were 72% males, mean age being 42.7 years. 
Control participants were 61% with mean age of 38.7 years. SCAT2 scores tended to 
improve among those mTBI patients with follow-up visits (p = 0.07); however, they did 
not tend to recover to scores of the healthy controls. Brain volumes were not statistically 
different between groups at the first visit (WM p = 0.71; GM p = 0.36). In mTBI patients, 
there was a reduction in GM volume between visits 1 and 2 (p = 0.0046). Although mean 
CVR indexes were similar (WM p = 0.27; GM p = 0.36; and WB p = 0.35), the correla-
tion between SCAT2 and CVR was negative in controls (WM-r = −0.59; p =  0.010; 
GM-r = −0.56; p = 0.016; brain-r = −0.58; p = 0.012) and weaker and positive in mTBI 
(brain-r = 0.4; p = 0.046; GM-r = 0.4; p = 0.048). SCAT2 correlated with GM volume 
(r = 0.5215, p = 0.0075) in mTBI but not in controls (r = 0.2945, p = 0.2355).
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inTrODUcTiOn
Traumatic brain injury (TBI) is a silent worldwide epidemic. It is 
estimated that mild injuries represent up to 75–90% of all brain 
injuries (1–3). Although the vast majority of patients recover well 
within weeks, up to 30% will suffer with persistent neurocogni-
tive, affective, and psychological symptoms (4), in a condition 
known as post-concussive syndrome (PCS). Persistent symptoms 
represent not only a personal burden to individual patients but 
also a socioeconomic issue, considering that most patients with 
TBI are relatively young (2).
Despite often disabling symptoms, routine imaging [comput-
erized tomography (CT) and magnetic resonance imaging (MRI)] 
is frequently normal or non-specific (5). Functional imaging 
appears to increase the sensitivity for detecting abnormalities 
(6), and it has been suggested that it might even help to predict 
outcome in mild traumatic brain injury (mTBI) patients (7). 
Advances in neuroimaging, especially in MRI techniques, now 
allow the identification of a subgroup of mTBI patients where 
microscopic axonal damage occurs despite normal standard 
imaging. Diffusion tensor imaging (DTI), measuring micro-
structural changes, suggests that there are indeed significant 
differences between mTBI patients and healthy individuals even 
if gross anatomical abnormalities cannot be seen on CT or MRI 
(8, 9).
The pathophysiological processes behind persistent post-
concussive symptoms are not clear. Altered cerebral blood flow 
(CBF) and disturbance of CBF regulatory mechanisms after 
mTBI may be related to post-injury symptoms (10). One impor-
tant mechanism for CBF regulation is cerebrovascular reactivity 
(CVR), which describes the degree of changes in intracranial ves-
sel diameter in response to chemical stimuli. CVR can be defined 
as the percentage change in CBF or CBF velocity [if transcranial 
Doppler (TCD) is used as the measurement tool] over the abso-
lute change in the stimuli. It has been suggested that altered CBF 
control mechanisms (CVR or autoregulation) following mTBI 
may help to identify patients at risk of prolonged post-concussive 
symptoms (11) or secondary injury (12).
Functional MRI (fMRI) based on blood-oxygen-level 
dependent (BOLD) sequences is able to detect changes in blood 
flow inferred from changes in concentrations of oxygenated 
hemoglobin. Therefore, it can be used to investigate CVR if the 
appropriate stimulus is provided. However, task-based fMRI is 
based on the assumption that neurovascular coupling is intact, 
i.e., regional flow will change in response to increased demand. 
Coupling is affected by many factors and may vary in different 
regions of the brain, and this assumption might not be correct 
in head injury (13–16). Recently, Maggio et al. (17) showed that 
changes in PaCO2 seem to influence neurovascular coupling but 
do not affect CVR measured using TCD and 5% carbon dioxide 
(CO2) inhalation. Although not a direct CBF measurement, the 
BOLD sequence provides a strong surrogate CVR measurement 
with high spatial resolution and is therefore able to detect small 
areas with abnormal CVR. Moreover, the use of CO2, a potent 
stimulus of CVR, provides a “global view” of vascular response 
and has been shown to be the most reproducible stimulus (18).
To investigate the relationship between CVR to CO2 and 
symptoms post-mild brain injury, we used fMRI-BOLD imaging 
coupled with precise CO2 manipulation (19) and a standard-
ized concussion assessment questionnaire [Sport Concussion 
Assessment Tool 2 (SCAT2)] (20) to evaluate symptom severity 
in a cohort of mTBI patients at two distinct time points following 
injury, and a matched control group.
MaTerials anD MeThODs
Research Ethics Board approval for the study at Sunnybrook 
Health Sciences Centre was obtained. A prospective cohort of 
25 patients with recently (<3 months) diagnosed mTBI and 18 
age- and sex-matched controls were recruited. mTBI was defined 
according to the criteria of the American Academy of Neurology 
(21) as a “traumatically induced physiological disruption of brain 
function,” as manifested by at least one of the following: loss of 
consciousness ≤30 min; amnesia time ≤24 h; alteration in mental 
state with a Glasgow Coma Scale (GCS) ≤13 after 30 min from 
injury; and focal neurological deficit(s) that may or may not be 
transient.
Patients with history of previous neurological (brain) surgery, 
previous moderate or severe head injuries or a recent concussion 
(<1 year), any associated major trauma, mTBI with significant 
posttraumatic CT changes (contusions, subdural hematomas), 
severe pulmonary disease, severe carotid stenosis or occlusion, 
or contraindications for MRI examination were excluded.
Mri and cO2 challenge
Two MRI scans with identical protocols were obtained at different 
occasions after injury. Time from injury to first visit was on aver-
age 63.6 days and to second visit 180 days. Functional magnetic 
resonance imaging of the brain (FMRIB) Software Library tools 
were used on the high resolution T1-weighted images to remove 
the skull (22) and correct for field inhomogeneities and perform 
automated segmentation into gray matter (GM), white matter 
(WM), and cerebrospinal fluid (CSF) (23). Region of interest 
(ROI) volumes were then extracted from GM and WM regions. 
MRI BOLD images are acquired with the following parameters: 
GRE-EPI TR/TE = 2000/30 ms, 255 volumes, flip angle = 90°, 
conclusion: There is a correlation between lower GM CVR indexes and lower per-
formance on SCAT2 in patients with mTBI, which seems to be associated with more
symptoms. This correlation seems to persist well beyond 120 days. mTBI may lead to a 
decrease in GM volume in these patients.
 
Keywords: cerebrovascular reactivity, concussion, head injury, traumatic brain injury
TaBle 2 | clinical scores and Mri data in healthy control and mTBi 
participants at the first clinic visit.
controls mTBi p
N 18 25
SSS 5.28 (±10.2) 35.72 (±24.8) 0.0001
SCAT2 91.5 (±5.7) 72.76 (±10.9) 0.0001
WM CVR 0.160 (±0.04) 0.1472 (±0.05) 0.28
GM CVR 0.28 (±0.06) 0.26 (±0.091) 0.37
Brain CVR 0.215 (±0.04) 0.20 (±0.072) 0.34
WM volume 417.1 (±47.2) 413.83 (±48.8) 0.71
GM volume 375.2 (±40.8) 365.14 (±47.4) 0.36
CO2 levels
Minimum 34.94 (±3.36) 34.63 (±5.03) 0.82
Maximum 44.0 (±4.04) 44.70 (±3.67) 0.56
This table describes group differences between symptom and imaging metrics for each 
group. p-values reported are based on Mann–Whitney non-parametric tests.
TaBle 1 | Patient demographics and mechanism of trauma.
controls mTBi
N 18 25
Male # (%) 11 (61) 18 (72)
Age μ (±SD)* 38.7 (±12.6) 42.7 (±16.3)
mTBI mechanism Fall N/A 10 (40%)
Assault N/A 2 (8%)
MVC N/A 9 (36%)
Sports N/A 3 (12%)
Blunt 
(industry)
N/A 1 (4%)
Days to MRI post-TBI (±SD) First visit N/A 63.5 days 
(±42)
Second visit N/A 180 days (±38)
Descriptive statistics were calculated for mild TBI and healthy control cohorts. No 
significant difference in age was found between TBI and healthy control participants. 
*p = 0.39, two sample t-test. Sex distribution was evaluated using a binomial 
probability test and did not differ between groups.
MVC, motor vehicle crash.
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64 × 64 matrix, 3.6 mm × 3.6 mm × 3 mm voxel size, axial (8:38), 
SPGR 3D sequence for co-registration and segmentation, multi-
echo T2 sequence, and 2D FLAIR.
Carbon dioxide was manipulated using prospective target-
ing of end-tidal CO2, as described previously by Slessarev et al. 
(19) Briefly, a mask connected to the computerized targeting 
rebreathing system (RespirAct™ – Thornhill Research, Toronto, 
ON, Canada) is taped over the mouth and nose. A 10-min period 
allowing acclimatization to wearing the breathing mask while in 
the MRI scanner is given, while anatomical MRI sequences are 
acquired. CO2 levels are raised 10  mmHg above baseline, kept 
for 45 s, and then returned to baseline. The sequence is repeated 
with hypercapnia of 130 and 90 s intervals between the two runs. 
MRI BOLD sequences are acquired during the time of CO2 
manipulation.
To obtain the CVR maps, from the tidal pCO2 waveforms 
generated by the RespirAct™, the end-tidal points are 
manually selected generating end-tidal pCO2 waveforms. MR 
and PETCO2 data are imported into the software Analysis of 
Functional Neuroimaging (AFNI) (24). The first raw images of 
each BOLD MRI acquisition are reviewed, and the first three 
volumes are discarded to allow for magnetization equilibra-
tion. To correct for motion, up to 9 (out of 72) volumes where 
there was appreciable change in head position between the 
anatomical acquisition and the BOLD MRI acquisition are 
excluded before generating maps of CVR. A linear slope of 
best fit approximates percentage of BOLD signal change per 
millimeter of mercury change in end-tidal CO2. Confidence of 
this fit is assessed with an r-value (Pearson product-moment 
correlation coefficient).
Cerebrovascular reactivity maps are generated by least 
squares fitting of the BOLD MRI signal waveform to the 
PETCO2 waveform on a voxel-by-voxel basis. From the fitted 
data, percentage MRI signal change per millimeter of mercury 
PETCO2 change on a voxel-by-voxel basis is calculated (=CVR). 
The anatomical images are segmented into GM and WM using 
statistical parametric mapping software (SPM5, Wellcome 
Department of Imaging Neuroscience, Institute of Neurology, 
University College, London, UK), and these masks are used to 
generate CVR maps.
symptom assessment
Symptoms were assessed using the SCAT2 (20) checklist, a 
standardized method used to evaluate injured athletes with 
concussion. This four-page questionnaire comprehensively and 
quickly assesses current symptoms, with tasks probing cognitive 
and balance abilities. It enables the calculation of the Symptom 
Severity Score (SSS) and the Standardized Assessment of 
Concussion (SAC) score. It should be highlighted that the SCAT2 
was designed for “sideline sports concussion” assessments and 
longitudinal data comparisons with a pre-injury baseline. When 
used to diagnose (sports) concussion, sensitivity (0.8–0.9) and 
specificity (0.9–1.0) of the SCAT2 is good, especially for the SSS 
and SAC components (25). GCS, mechanism of injury, loss of 
consciousness and duration, initial neurological examination, 
and imaging results were also recorded. SCAT assessments were 
performed within 1 day of each MRI.
statistical analysis
Statistical Analysis was performed using SPSS 22. Continuous data 
are presented as mean ± SD. Paired t-tests were used to compare 
the variables within TBI patients at two time points. Normality of 
distribution of the data was tested with the Shapiro–Wilk test, and 
non-parametric tests (Mann–Whitney) were used to compare 
CVR indexes and volumetric data among the groups. Analysis 
of covariance including age, sex, and presence of TBI was used to 
evaluate the influence of each variable on SCAT2 scores. Pearson 
product-moment correlation coefficient was used to measure the 
correlation between CVR indexes and SCAT2 scores, SSS scores, 
age, and sex.
resUlTs
Patient demographics and mechanism of trauma are shown in 
Table 1. Mean age was similar between the groups (p = 0.39). No 
difference in sex distribution between groups was observed.
Table 2 shows the results of clinical (SCAT2, SSS) and radio-
logical evaluations (MRI CVR indexes, GM, and WM volumes) 
TaBle 4 | cVr correlates among TBi patients (N = 19).
WM cVr gM cVr Whole brain cVr
SCAT2 NS r = 0.49 r = 0.48
p = 0.03 p = 0.04
WM volume r = −0.46 NS NS
p = 0.05
GM volume NS NS NS
Pearson correlation coefficients were calculated for the mTBI patients (n = 19) who 
completed two visits. Significant correlations are displayed.
NS, not significant.
TaBle 3 | symptom and Mri evaluations of longitudinally followed mTBi 
patients (N = 19).
mTBi visit 1 mTBi visit 2 p
Mean days post-TBI 63.5 days (±42) 180 days (±38)
SCAT2 72.76 (±10.9) 77.8 (±14.22) 0.07
WM CVR 0.1472 (±0.05) 0.1468 (0.40) 0.50
GM CVR 0.26 (±0.091) 0.25 (±0.074) 0.49
Brain CVR 0.20 (±0.072) 0.20 (±0.05) 0.45
WM volume 413.83 (±48.8) 410.97 (±53.9) 0.89
GM volume 365.14 (±47.4) 351.4 (±42.3) 0.005
Paired t-tests were performed to evaluate difference in symptom scores and imaging 
metrics for TBI patients returning for visit 2.
FigUre 1 | example of an individual cVr map 1 week after injury (a). CVR is calculated voxel-by-voxel and color-coded, with lower CVR values coded as 
blue. Note, in (a), the “blue areas” are more evident in the left frontoparietal [where a few regions of interest are highlighted (circles)] and periventricular regions. The 
decreased CVR in the ventricles is an expected response – please see text for detail. In the follow-up scan (B), 2 months after injury, note the decrease in “blue 
areas” indicating return of CVR to normal.
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in controls and mTBI patients at the first clinic visit. Brain vol-
umes were similar between controls and mTBI at visit 1 for both 
WM (p = 0.71) and GM (p = 0.36). SSSs and SCAT2 scores were 
significantly different in controls and TBI in visit 1 (p = 0.0001 for 
both). Although age was negatively correlated to SCAT2 scores for 
mTBI patients in the first (r = −0.62, p = 0.0010) and follow-up 
visits (r = −0.46, p = 0.048) as well as healthy controls (r = −0.6, 
p = 0.007), analysis of variance, including age and sex, showed 
that mTBI continued to have a significant interaction with SCAT2 
scores (mTBI: p =  0.00001; age: p =  0.02; sex: p =  0.13). This 
difference was still present if age and sex were included in analysis 
of variance (mTBI: p = 0.0003; age: p = 0.43; sex: p = 0.25).
Table 3 shows results of the 19 TBI patients who returned for 
a follow-up visit.
In the mTBI cohort, between the first visit and the follow-up, 
there was a reduction in GM volume (p = 0.005) but not WM 
volume (p = 0.89). No difference was detected between early and 
late mean CVR indexes in the mTBI patients with a follow-up 
visit (GM: p = 0.49; WM: p = 0.50; brain CVR: p = 0.45), despite 
noticeable improvement in the CVR maps in some subjects 
(Figure  1). Table  4 shows where significant correlations were 
found between symptoms and imaging metrics for the mTBI 
patients (n = 19) with follow-up visits. Only significant correla-
tions are displayed.
scaT2 scores and cVr
A negative correlation between SCAT2 scores and CVR was 
seen in controls for WM (r = −0.59; p =  0.01, Pearson), GM 
(r = −0.56; p = 0.016, Pearson), and WB (r = −0.58; p = 0.01, 
Pearson). Interestingly, in mTBI patients, the correlation between 
CVR and SCAT2 scores was positive and only present for WB 
(r = 0.4; p = 0.046, Pearson) and GM (r = 0.4; p = 0.05, Pearson) 
in visit 1. SCAT2 scores were strongly correlated with GM volume 
(r = 0.52, p = 0.008, Pearson) in mTBI patients (first visit) but not 
in controls (r = 0.29, p = 0.24, Pearson) (Figure 2).
We analyzed the data for the patients with follow-up visit 
only to confirm that the six patients lost for follow-up did not 
influence these results. For the 19 patients with CVR MRI at 
FigUre 2 | correlation between scaT2 scores and cVr indexes. Subjects with mTBI are shown in the first two charts. In (a), the whole brain CVR is shown, 
and in (B), the gray matter CVR is shown. Healthy controls are shown in chart (c): note the negative correlation between CVR values and SCAT2 performance.
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two time points, significant correlations between SCAT2 scores 
and CVR and brain volumes were demonstrated. Please refer to 
Tables 3 and 4.
DiscUssiOn
The main findings in this study were that (1) patients with mTBI, 
even if minimally symptomatic, showed lower SCAT2 scores 
compared to controls, a finding that persisted in the 180 days after 
injury; (2) in patients with mTBI, a positive correlation between 
SCAT2 scores, GM, and brain CVR indexes was seen, while in 
healthy controls this correlation was negative; this correlation is 
more evident in the initial test (average 60 days post-injury); and 
(3) a detectable loss in GM volume in patients was evident in the 
mTBI patients when comparing early and delayed MRIs.
In our cohort, as expected, patients with mTBI were much 
more likely to complain of symptoms and performed signifi-
cantly worse on the SCAT2 test compared to controls during the 
initial assessment for the study, on average 60 days after injury. 
Interestingly, although there was a trend for improvement in 
SCAT2 scores (p = 0.06) during follow-up, on average 180 days 
post-injury, the SSS did not change. Despite performing better, 
patients were as likely to report and complain of symptoms related 
to the injury at 6 months than they were at 2 months. Even though 
most of the reported symptoms are non-specific (e.g., headache, 
dizziness, and feeling generally “slowed down” cognitively), these 
patients also scored lower in the examiner driven portion of the 
test, where the SSS scores are excluded.
Although improved SCAT2 scores of mTBI patients in follow-
up were still significantly lower than the controls’ scores, it sug-
gested that the improvement might take longer than expected. 
This inability to perform well so many months after injury might 
influence the patient’s perception of their clinical condition, as 
reflected in similar SSS between the first and follow-up visits.
The primary brain injury related to TBI occurs at the moment 
of impact, with diffuse axonal injury being the most important 
primary lesion. Sudden acceleration–deceleration creates shear-
ing forces in the brain that can lead to axonal damage, from minor 
intra-axonal changes to major dysfunctions in ion transport and 
intra-axonal flow leading to axon swelling and lysis, propor-
tional to the severity of the injury. With axonal injury, release 
of excitatory neurotransmitters, microvascular dysfunction and 
hemorrhage, and edema might ensue (26).
Diffuse axonal injury is a consistent finding in mild, moder-
ate, and severe traumatic head injury, with increasing severity in 
worse injuries. On the other hand, secondary brain injury devel-
ops within hours after impact and mainly consists of ischemia (2), 
being well recognized as a cause of poor outcome in moderate 
and severe TBI (27, 28). More recently, it has been suggested that 
patients with mild injuries might also be at risk of secondary 
injury (12, 29, 30).
Maintaining adequate CBF is one of the cornerstones of TBI 
management (31–33), and the importance of cerebral hemody-
namics and its disruption leading to hypoperfusion or hyperper-
fusion situations are well recognized as important mechanisms 
of further neuronal damage after TBI or stroke. Historically, 
this has been discussed in the setting of severe TBI, but with the 
demonstration of altered CBF in milder injuries, it might also be 
of importance in milder cases.
Diffuse morphological changes, including microscopic axonal 
injury, have been shown in humans after mTBI (2, 34–36). In a 
primate model of acceleration injury, Maxwell et al. demonstrated 
morphological changes in the foot processes of perivascular 
astrocytes with persistent increase in endothelial projections 
in the arterioles and venules throughout the brain (37). These 
morphological changes cannot be visualized even with modern 
imaging, but it is reasonable to assume that they may lead to 
alterations in the cerebral microvasculature that could affect 
cerebral hemodynamics.
Reduction of CBF early after TBI has been well demonstrated 
after severe TBI (38), and disruption of autoregulation (39, 40) 
and reactivity to CO2 (41, 42) have been shown to correlate with 
outcome after severe injury. Disturbances in autoregulation (12, 
43) and CVR (3, 11) have also been shown in mTBI. Although a 
link between CVR and clinical symptoms after mild injury has 
been suggested (11), little is known about the temporal evolution 
of the CVR impairment, if present, and its anatomical distribu-
tion and regional specificity, if any.
Another possible cause for changes in CBF after mTBI is 
inflammation. Changes in inflammatory cell marker expression 
and cellular infiltration (44) and increased cytokines (e.g., IL 2, IL 
6, and TNF alpha) have been reported after mTBI. Inflammatory 
FigUre 3 | Mild TBi patients’ gray matter volume measurements 
calculated at day 63 and day 180. Paired t-tests were performed, with 
significance set at p < 0.05. Larger variability is observed at the earlier visit.
FigUre 4 | Visit 1 white matter cVr and volumes: a negative 
correlation between WM cVr and WM volumes among mTBi patients 
is observed at only 2 months after injury. Pearson’s correlation coefficient 
r = −0.46, p = 0.05.
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cell migration to the venous vasculature and increased leukocyte–
endothelium interactions in venules after TBI can result in local 
inflammatory response, microthrombi formation, and obstruc-
tion of venous outflow and also influence the endothelial cells 
and local production of vasoactive substances, besides potentially 
increasing vessel wall rigidity, changing venous hemodynamics, 
and decreasing intracranial compliance (45).
Our results show a correlation between lower SCAT2 scores, 
indicating poorer performance, and lower CVR indexes, indica-
tive of a blunted or absent response from the microvasculature 
to CO2 changes. Although impairment of CVR after mTBI was 
demonstrated before (11, 46) the use of MRI imaging allows 
better anatomical discrimination. We showed that GM CVR is 
better correlated with symptoms; this finding is in agreement 
with previous studies using TCD, since TCD is usually used to 
measure middle cerebral artery (MCA) blood flow velocity, the 
main supplier of hemispheric GM.
We found a decrease in GM volume between the 2- and 
6-month visits, when looking at the mTBI (Figure  3) patients 
who were longitudinally followed. Van der Naalt et al. found that 
approximately a third of patients with mild and moderate head 
injury have focal atrophy in the frontal and temporal regions 
on MRI in the chronic phase, and that the degree of atrophy is 
predictive of outcome (47). Metting et al. demonstrated frontal 
hypoperfusion in the acute phase of mTBI (48). They also report 
decreased cerebral blood volume (CBV) that correlated with 
decreased fractional anisotropy (FA) in DTI MRI performed on 
average 160 days later.
Hofman et al. compared early MR images and SPECT scans 
after mTBI and found an association between abnormal imag-
ing (MRI and/or SPECT) in the acute phase (less than 5 days) 
and brain atrophy after 6  months, yet with little correlation to 
general neurocognitive outcome (49). Interestingly, there was no 
correlation between MRI and SPECT regarding the presence and 
location of posttraumatic lesions, even though atrophy was corre-
lated to the presence of lesions in either test. Because the majority 
of abnormal SPECT findings were related to hypoperfusion, the 
authors speculate that this could indicate early hypoperfusion 
that would lead to delayed atrophy.
In our cohort, none of the patients had parenchymal post-
traumatic lesions, and therefore lesion resolution cannot be the 
underlying process to explain the atrophy. It is possible that all 
these findings reflect many aspects of the same pathophysiologi-
cal process where the end result is the decreased perfusion: diffuse 
microscopic changes in astrocytes and axons in the acute phase of 
injury lead to dysfunction of the microcirculation and impaired 
reactivity. One hypothesis is that the microcirculation might be 
in a state of vasoconstriction due to local changes in astrocyte 
foot processes and inflammatory reaction, which might result in 
decreased in CBV and eventual atrophy. The negative correlation 
(Figure 4) found between WMCVR and WM volume might offer 
further support to the theory of vasoparalysis: more affected 
vessels, without capacity of vasodilatation, will not increase in 
diameter with increasing levels of CO2, resulting in lower WM 
volumes. The lack of CVR reactivity would be a marker for more 
severe microstructural injuries within the mTBI spectrum.
One of the advantages of using prospective targeting to CO2 
levels is that stimulation of the vasculature is independent of 
neurovascular coupling. Disruption of coupling is well described 
after TBI (50, 51), and since BOLD MRI is based ultimately 
on the metabolic changes, often following increased neuronal 
activity that results in alteration of CBF and the proportions 
of oxy and deoxyhemoglobin, loss of neurovascular coupling 
has the potential to impact BOLD results. By using a method 
to manipulate CO2 directly, we can measure BOLD responses 
that are independent of neuronal activity. Accordingly, none 
of our subjects were asked to perform any specific task, which 
theoretically should decrease the influence coupling could have 
on our findings. Furthermore, recently Maggio et  al. showed 
that hypercapnia affects neurovascular coupling, but it does not 
change CVR (17).
TaBle 5 | comparison of clinical scores and Mri data within mTBi 
patients after early visit (60 days).
mTBi no 
follow-up
mTBi with 
follow-up
p
N 6 19
Male # (%) 5 (80) 13 (69) 0.64
Age μ (±SD) 39.5 (±17.7) 43.7 (±16.35) 0.59
Mean days after trauma 
μ (±SD)
59.7 (±36.12) 64.9 (±45.57) 0.79
SSS 37 (±14.9) 35.3 (±27.6) 0.88
SCAT2 73.3 (±14.7) 72.6 (±9.94) 0.88
WM CVR 0.14 (±0.08) 0.15 (±0.04) 0.52
GM CVR 0.24 (±0.16) 0.26 (±0.066) 0.66
Brain CVR 0.19 (±0.11) 0.20 (±0.01) 0.58
WM volume 423.3 (±55.5) 410.8 (±47.7) 0.59
GM volume 364.3 (±67.15) 365.4 (±41.7) 0.96
This table is included to highlight the homogeneity within the sample of TBI patients. 
The subset of six patients who were not able to complete a follow-up MRI or clinic visit 
show comparable values on symptom scores and imaging indices. These comparisons 
examine the data collected at visit 1 only.
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Glushakova et al. characterized the acute phase of microvas-
cular damage in TBI when breakdown of the blood–brain barrier, 
leukocyte translocation, and microglia activation can be seen, 
followed later by chronic changes, including micro-hemorrhages, 
iron deposit, and inflammation, and suggest that this process is 
initiated by mechanical injury to the microcirculation (52). It is 
possible that one of the phenotypes of this injury is the loss of the 
capacity to react to changes in CO2. The functional disruption 
of neuronal networks can lead to delays and disorganization of 
neuronal activity, as demonstrated in electrophysiological studies 
using magnetoencephalography in mTBI patients (4, 53).
We were surprised by the opposite correlation between SCAT2 
scores and CVR in mTBI and healthy controls. In mTBI patients, 
CVR indexes were on average lower (0.20 ± 0.072) compared to 
controls (0.22 ± 0.04), but the difference was not significant. TBI 
patients with lower CVR indexes had the lowest SCAT2 scores 
and healthy individuals with the highest CVR indexes had the 
lowest SCAT2 scores in each group, respectively. It is well estab-
lished that both hypoperfusion and hyperperfusion can cause 
harm, and we speculate that an “ideal range” for CVR might 
exist and individuals below or above that range may not be able 
to perform at their best. This observation has to be considered 
keeping in mind that the test used to evaluate performance is 
limited, and in most cases used for sideline assessment of acute 
concussion only.
Our paper has limitations. We acknowledge the small num-
bers and recognize that results may not be generalizable to the 
mTBI population, especially the elderly. Six patients were lost 
to MRI follow-up. This might have resulted in selection bias 
where patients with more symptoms were more likely to return. 
However, we compared the results between the mTBI patients 
with and without follow-up visit, and the groups were similar 
(Table 5). We did not include CSF in the analysis, and Figure 1 
demonstrates that reactivity tends to be negative (“blue”) in the 
ventricles. It has been shown that the BOLD time course from 
the ventricles display inverse correlation with the partial pressure 
of end-tidal CO2 (PetCO2) in normal healthy volunteers, likely 
caused by dilatation of the ventricular blood vessels, which dis-
places CSF, generating the apparently negative CVR within the 
ventricular system (54). Further analyses, beyond the scope of 
this initial work, would include correlations among patients with 
confirmed DAI on MRI.
Traumatic brain injury is more prevalent in young males, and 
accordingly, we had more males in mTBI group. The expected 
frequency of females in the mTBI group, based on the control 
group numbers, would be 15. Sex differences in CVR have been 
reported in healthy individuals, with women demonstrating 
slightly higher reactivity indexes (55). Due to logistic issues, 
there is a large variation in the time between injury and first 
scan. This might have affected our results since changes in reac-
tivity and autoregulation after injury are likely to be a dynamic 
process.
As mentioned above, we used SCAT2 questionnaire. The 
questionnaire is not a comprehensive test and does not replace 
neuropsychological testing. However, written neuropsychologi-
cal tests are time-consuming and require trained personnel, and 
while computer-based tests are more user friendly, there is no 
consensus on effectiveness (56). Also, it is a tool designed to 
diagnose concussion in the acute/subacute period and is usually 
collected longitudinally. Its use in a more chronic phase after 
head injury might not be ideal. However, because the SCAT2 
is designed for use as a longitudinal follow-up tool, in this case, 
we felt it would be an appropriate method to measure evolution 
of posttraumatic symptoms. Our choice of the SCAT2 [which 
includes balance error scoring system (BESS) – a sensitive test 
for concussion diagnosis] was based on it being easy to apply, 
widely used, and easily reproducible, thus facilitating testing and 
re-testing.
cOnclUsiOn
Our findings suggest that there is a relationship between the 
impairment of CVR to CO2 and performance on the SCAT2 score 
in patients with mTBI. We also noticed that symptoms and CVR 
impairment could be seen even after 6 months from an appar-
ently very minor injury. These findings suggest that the reactivity 
to CO2 might be developed into an imaging marker for mTBIs, 
especially if longitudinal follow-up is feasible.
We also noticed significant decrease in GM volume in follow-
up imaging. This has been demonstrated in more severe injuries 
or milder injuries with evidence of parenchymal lesions in acute 
imaging. Our findings suggest that even the mildest injuries, 
without acute findings in CT and/or MRI, might lead to brain 
atrophy. Although the test in its current state might not be useful 
to detect the acute concussion in an ER setting, it might be to 
monitor sports injuries and head trauma in other more controlled 
environments, offering a more objective measure of effects of 
minor injuries in brain physiology.
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